UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
PREV
NEXT
1
2
3
Pharma
HeadLine News
Amgen Korea wins new indication for acute lymphobl...
Amgen Korea has received an expanded indication for Blincyto, a treatment for acute lymphoblastic leukemia (ALL), for treating minimal residual disease (MRD) in relapsed and refractory ALL. Amgen Korea's ALL ...
Hospital
HeadLine News
Doctors to end strike as government puts healthcar...
The medical community agreed to end the ongoing strike, as the government and the ruling party promised to put on hold plans of increasing doctors and establishing a state-run medical school. The agreement between the do...
Policy
HeadLine News
Despite slowing down virus cases, tight restrictio...
Korea reported new Covid-19 cases of below 200 for two consecutive days on Friday, but the government extended the Level 2.5 social distancing scheme in the greater Seoul area for another week.“Although the number of con...
여백
People
176 civic groups furious over government-doctors deal
Labor and civic groups intensely criticized the go...
Device/ICT
UBcare wins patent for tech to monitor suspected infectious diseases
UBcare, a company specializing in digital healthca...
Pharma
SCM Lifescience punished for delaying adverse reaction report
The Ministry of Food and Drug Safety said it impos...
여백
Iraq approves Hutox as 1st BTX product
Huons said that Iraqi health authorities have approved Hutox, its botu...
2020-09-04 |
Pharma
‘Cyramza helped improve gastric cancer treatment in Korea’
Lilly’s Cyramza (ingredient: ramucirumab), an inhibitor of vascular en...
2020-09-03 |
Hospital
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
Novavax unveiled the successful results of the phase-1 clinical trial ...
2020-09-03 |
Pharma
여백
Chong Kun Dang to conduct P2 trials of Covid-19 therapy in Russia
Chong Kun Dang's anticoagulant and acute pancreatitis treatment Nafabe...
2020-09-03 |
Pharma
Recovered Covid-19 patients suffer from aftereffects – for long
Many Covid-19 patients have been completely cured by enduring physical...
2020-09-02 |
Policy
여백
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
The European Society of Cardiology recently announced the 2020 ESC gui...
2020-09-02 |
Pharma
여백
여백
여백
Pharmaceuticals, CROs have hard time doing clinical trials amid prolonged pandemic
8 in 10 clinical professors willing to act collectively
Daewoong to expand indication of Nabota in US
New virus cases fall below 200 but critical patients surge
Nation struggles to secure beds, workforce for severe Covid-19 patients
여백
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
[Column] Correct diagnosis leads to proper treatment
FDA grants priority review to Hanmi’s Oraxol
New virus cases slow down – for now
여백
NEWS MORE
여백
여백
Most Viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
여백
People
176 civic groups furious over government-doctors deal
‘Increase of doctors does not lead to more pediatric surgeons’
Opponents to increasing doctors point to failure of medical graduate schools
여백
Special
Hospitals resort to robots amid Covid-19 pandemic
[Photo News] Trainee doctors hit streets against increasing physicians
[Interview with global pharma] 'Roche Korea's endeavors to build agile corporate culture'
여백
Back to Top